CEO Chat: Baird Medical's Mark Saxton on the U.S. Microwave Ablation Opportunity | NASDAQ: BDMD

Zacks Small Cap Research sat down with Mark Saxton, CEO of the U.S. Region for Baird Medical (NASDAQ: BDMD), a leading provider of microwave ablation technology for thyroid nodules, breast disease, and other soft-tissue applications. Saxton breaks down how microwave ablation compares clinically to radiofrequency ablation, why the company is prioritizing its U.S. market entry now, the multi-million-patient addressable opportunity in thyroid disease that remains largely untreated, the recurring-revenue model behind its disposable needle system, and the broader technology roadmap, including AI-powered surgical software and early-stage ablation robotics. https://scr.zacks.com/home/default.aspx https://bairdmed.com/ 📍 Subscribe to Zacks Investment Awareness for all the latest updates on small and micro cap stocks. 📩 Subscribe to our email list here: https://scr.zacks.com/subscribe/free-... 00:00 Introduction to Baird Medical and Guest Background 02:25 Advantages of Microwave Ablation: Speed, Safety, and Patient Comfort 04:57 US Market Opportunity and Strategic Timing 07:20 Targeting Physicians and Practice Settings 10:19 Expanding Beyond Thyroid: Broader Indications 11:09 Product Overview: System and Disposable Needles 12:06 Physician Response and Adoption Potential 13:36 Global Expansion and Future Technologies 14:36 Future Product Developments and Innovation 14:58 Final Remarks and Investment Outlook #BDMD #BairdMedical #market #smallcapstocks #smallcaps #investing _______________________________________________________________________ DISCLOSURE: The Zacks SCR analyst conducting this Chat hereby certifies that the views expressed accurately reflect the personal views of the analyst about the subject securities and issuer. Zacks SCR certifies that no part of any analyst’s compensation was, is, or will be, directly or indirectly, related to the recommendations or views expressed in this Chat. Zacks SCR believes the information used for the creation of this Chat has been obtained from sources considered to be reliable, but we can neither guarantee nor represent the completeness or accuracy of the information herewith. Such information and the opinions expressed are subject to change without notice. Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm engaged by the issuer, for providing research coverage for a period of no less than one year. CEO/Fireside Chats, as mentioned here, are part of the service Zacks SCR provides, and Zacks SCR receives payments totaling a maximum fee of up to $50,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE: https://scr.zacks.com/disclaimer/defa...